C29H41NO7
Neat
515.65
Room Temperature
Candoxatril; 123122-55-4; 4-[[1-[(2S)-3-(2, 3-dihydro-1H-inden-5-yloxy)-2-(2-methoxyethoxymethyl)-3-oxopropyl]cyclopentanecarbonyl]amino]cyclohexane-1-carboxylic acid; UK-79, 300; UK-79300; ACP75508EE; DTXSID6047286; [4(S)-cis]-4-[[[1-[3-[(2, 3-dihydro-1H-indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid; cis-4-{[(1-{(2S)-3-(2, 3-dihydro-1H-inden-5-yloxy)-2-[(2-methoxyethoxy)methyl]-3-oxopropyl}cyclopentyl)carbonyl]amino}cyclohexanecarboxylic acid; Cyclohexanecarboxylic acid, 4-[[[1-[(2S)-3-[(2, 3-dihydro-1H-inden-5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]-, cis-; 4-({1-[(S)-2-(Indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid; Cyclohexanecarboxylic acid, 4-(((1-(3-((2, 3-dihydro-1H-inden-5-yl)oxy)-2-((2-methoxyethoxy)methyl)-3-oxopropyl)cyclopentyl)carbonyl)amino)-, (4(S)-cis)-; Candoxatril [USAN:INN:BAN]; UNII-ACP75508EE; Candoxatrilo; Candoxatril (JAN/USAN/INN); (alphaS)-1-((cis-4-Carboxycyclohexyl)carbamoyl)-alpha-((2-methoxyethoxy)methyl)cyclopentanepropionic acid, alpha-5-indanyl ester; (alphaS)-1-[(cis-4-Carboxycyclohexyl)carbamoyl]-alpha-[(2-methoxyethoxy)methyl]cyclopentanepropionic acid and alpha-5-indanyl ester; CANDOXATRIL [MI]; CANDOXATRIL [INN]
4-[[1-[(2S)-3-(2 and 3-dihydro-1H-inden-5-yloxy)-2-(2-methoxyethoxymethyl)-3-oxopropyl]cyclopentanecarbonyl]amino]cyclohexane-1-carboxylic acid
InChI=1S/C29H41NO7/c1-35-15-16-36-19-23(27(33)37-25-12-9-20-5-4-6-22(20)17-25)18-29(13-2-3-14-29)28(34)30-24-10-7-21(8-11-24)26(31)32/h9,12,17,21,23-24H,2-8,10-11,13-16,18-19H2,1H3,(H,30,34)(H,31,32)/t21?,23-,24?/m0/s1